Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group-Reference-Cited by-同舟云学术

Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group

Published:2015-10 Issue:4 Volume:173 Page:1015-1023
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Hurabielle C.¹²,Ingen-Housz-Oro S.¹³,Ortonne N.³⁴,Cornillet-Lefèbvre P.⁵,Merah A.⁶,D'Incan M.³⁷,Joly P.³⁸,Franck N.³⁹,Estève E.³¹⁰,Maubec E.³¹¹,Grange F.³¹²,Machet L.³¹³,Laroche L.³¹⁴,Barete S.³¹⁵,Dalac S.³¹⁶,Mortier L.³¹⁷,Michel C.³¹⁸,Quereux G.³¹⁹,Saiag P.³²⁰,Ram-Wolff C.²³,Lenormand B.²¹,Wechsler J.³⁴,Bastuji-Garin S.²²,Bagot M.²³,Delfau-Larue M.H.³⁶

Affiliation:

1. Dermatology Department; AP-HP; Henri Mondor Hospital; 51 Avenue du Maréchal de Lattre de Tassigny 94000 Créteil France

2. Dermatology Department; AP-HP, and INSERM U976 Saint-Louis Hospital; Paris France

3. Cutaneous Lymphoma French Study Group (GFELC); Paris France

4. Pathology Department; AP-HP; Henri Mondor Hospital; 51 Avenue du Maréchal de Lattre de Tassigny 94000 Créteil France

5. Laboratory of Haematology; Hôpital Robert Debré; Reims France

6. Biological Immunology and Haematology Department; AP-HP; Henri Mondor Hospital; 51 Avenue du Maréchal de Lattre de Tassigny 94000 Créteil France

7. Dermatology Department; CHU - Hôpital Estaing; Clermont-Ferrand France

8. Dermatology Department; Rouen University Hospital; INSERM U905; Institute for Research and Innovation in Biomedicine (IRIB); Rouen University; Rouen France

9. Dermatology Department; AP-HP; Cochin Hospital; Paris France

10. Dermatology Department; CHR Orléans; Orléans France

11. Dermatology Department; AP-HP; Bichat Hospital; Paris France

12. Dermatology Department; Hôpital Robert Debré and EA 7319; Université de Reims Champagne-Ardenne; Reims France

13. Dermatology Department; CHRU de Tours; Tours, INSERM U930; Université François Rabelais de Tours; Tours France

14. Dermatology Department; AP-HP; Avicenne Hospital; Bobigny France

15. Dermatology Department; AP-HP; Pitié Salpêtrière; Paris France

16. Dermatology Department; CHU Dijon; Dijon France

17. Dermatology Department; CHRU Lille; Lille France

18. Dermatology Department; CHU Mulhouse; Mulhouse France

19. Dermatology Department; CHU Nantes; Nantes France

20. Dermatology and Oncology Department; EA 4340; University of Versailles-SQY; CHU A Paré; Boulogne-Billancourt France

21. Haematology Department; Rouen University Hospital; Rouen France

22. Clinical Research Centre; AP-HP; Henri Mondor Hospital; 51 Avenue du Maréchal de Lattre de Tassigny 94000 Créteil France

Funder

Association pour la Recherche sur le Cancer

Institut national de la santé et de la recherche médicale

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.14017/fullpdf

Reference48 articles.

1. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases;Bradford;Blood,2009

2. Report of the committee on staging and classification of cutaneous T-cell lymphomas;Bunn;Cancer Treat Rep,1979

3. Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients;Zackheim;J Am Acad Dermatol,1999

4. Primary cutaneous T-cell lymphoma: review and current concepts;Siegel;J Clin Oncol,2000

5. The management of mycosis fungoides at Stanford - standard and innovative treatment programmes;Hoppe;Leukemia,1991

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T-Cell Monoclonality in the Blood and the Skin Correlates With Poor Response to Treatment in Mycosis Fungoides;Clinical Lymphoma Myeloma and Leukemia;2023-02

2. Expanding the Molecular Landscape of Cutaneous T-Cell Lymphoma;Advances in Molecular Pathology;2022-11

3. Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2022-10-20

4. Cutaneous T‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2021-08-02

5. Evolution of Dupilumab-Associated Cutaneous Atypical Lymphoid Infiltrates;The American Journal of Dermatopathology;2021-07-09